These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21543414)

  • 1. Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake.
    Fiore MC; Jimenez PM; Cremonezzi D; Juncos LI; García NH
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F263-70. PubMed ID: 21543414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin improves sodium handling and decreases blood pressure in salt-loaded rats with chronic renal insufficiency.
    Juncos LI; Martín FL; Baigorria ST; Pasqualini ME; Fiore MC; Eynard AR; Juncos LA; García NH
    Nutrition; 2012 Sep; 28(9):e23-8. PubMed ID: 22698702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH; Schwabe O; Hecker M
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased salt sensitivity induced by sensory denervation: role of superoxide.
    Song WZ; Chen AF; Wang DH
    Acta Pharmacol Sin; 2004 Dec; 25(12):1626-32. PubMed ID: 15569407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.
    Zhou MS; Schuman IH; Jaimes EA; Raij L
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F53-9. PubMed ID: 18463318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
    Zhou MS; Jaimes EA; Raij L
    Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide.
    Dayoub JC; Ortiz F; López LC; Venegas C; Del Pino-Zumaquero A; Roda O; Sánchez-Montesinos I; Acuña-Castroviejo D; Escames G
    J Pineal Res; 2011 Oct; 51(3):324-30. PubMed ID: 21585521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.
    Zhou MS; Tian R; Jaimes EA; Raij L
    Am J Hypertens; 2014 Jun; 27(6):873-80. PubMed ID: 24413709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X; Ma Y; Ruan Y; Fu G; Wu S
    Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
    Torrens C; Kelsall CJ; Hopkins LA; Anthony FW; Curzen NP; Hanson MA
    Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
    Chen GP; Yao L; Lu X; Li L; Hu SJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt and nitric oxide inhibition induced hypertension: the role of prostacycline and 8-isoprostane.
    Ilhan S; Oktar S; Sahna E; Aksulu HE
    Clin Exp Hypertens; 2011; 33(2):84-8. PubMed ID: 21214402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
    Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
    Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
    Kato N; Liang YQ; Ochiai Y; Jesmin S
    Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
    Heeba G; Hassan MK; Khalifa M; Malinski T
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.